0001209191-24-003010.txt : 20240208 0001209191-24-003010.hdr.sgml : 20240208 20240208194013 ACCESSION NUMBER: 0001209191-24-003010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lian Brian CENTRAL INDEX KEY: 0001614578 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 24610819 MAIL ADDRESS: STREET 1: C/O SEELOS THERAPEUTICS, INC. STREET 2: 300 PARK AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-08 0 0001607678 Viking Therapeutics, Inc. VKTX 0001614578 Lian Brian C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 1 1 0 0 President & CEO 1 Common Stock, par value $0.00001 per share 2024-02-08 4 M 0 49079 1.23 A 2313961 D Common Stock, par value $0.00001 per share 2024-02-08 4 S 0 49079 25.75 D 2264882 D Common Stock, par value $0.00001 per share 2024-02-08 4 M 0 140000 4.65 A 2404882 D Common Stock, par value $0.00001 per share 2024-02-08 4 S 0 60000 25.95 D 2344882 D Common Stock, par value $0.00001 per share 2024-02-08 4 S 0 80000 26.95 D 2264882 D Common Stock, par value $0.00001 per share 2024-02-08 4 S 0 40000 27.45 D 2224882 D Common Stock, par value $0.00001 per share 2024-02-08 4 S 0 40000 28.90 D 2184882 D Stock Option (right to buy) 1.23 2024-02-08 4 M 0 14148 0.00 D 2018-01-05 2027-01-05 Common Stock 14148 0 D Stock Option (right to buy) 1.23 2024-02-08 4 M 0 34931 0.00 D 2017-01-05 2027-01-05 Common Stock 34931 0 D Stock Option (right to buy) 4.65 2024-02-08 4 M 0 140000 0.00 D 2019-01-19 2028-01-19 Common Stock 140000 0 D The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023. 25% of the shares subject to the option vested on each one year anniversary of the grant date. /s/ Michael Morneau, as Attorney-in-Fact 2024-02-08